the market?
EXACT Sciences Corp
NASDAQ: EXAS
10.54
-0.04
(-0.38%)
Extended Hours:
$10.54
$0.00
(0.00%)
| Today's Open | $10.35 |
|---|---|
| Previous Close | $10.58 |
| Daily Range | $10.31 - $10.69 |
| 52-Week Range | $6.93 - $12.30 |
| Market Cap | $675.6M |
| P/E Ratio | -12.30 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 600,858 |
| Average Daily Volume | 2,239,881 |
| Current FY EPS | -$0.73 |
How do you think EXAS
will perform against the market?
Top EXAS Bull/Bear Pitches
NHWeston (9.85)
Submitted
June 1, 2011
Exact Sciences stakes its future on a pioneering and extremely promising gambit - replacing the colonoscopy with a highly-reliable, completely non-invasive test for rectal and intestinal cancer. Its t … More
zzlangerhans (< 20)
Submitted
October 24, 2011
Exact's share price seems to be getting ahead of itself yet again as the Cologuard trial enters the early stages of an enrollment process that will likely extend at least another 12 months. That means … More
News & Commentary
Why Exact Sciences Is Poised to Underperform
Market-lagging returns could be written in this 2-Star.Exact Sciences Reports First-Quarter 2013 Financial Results, Announces Addition to Board of Director
3 Horrendous Health-Care Stocks This Week
Disappointment after disappointment. That's the story for these stocks.Not Exactly What Investors Were Looking For
How can a stock react so badly to a successful phase 3 trial?Why EXACT Sciences Shares Nosedived
High expectations crush EXACT Sciences top-line clinical trial results for its colon cancer diagnostic test.Sector
Healthcare
Industry
Drugs
EXACT Sciences Corp (EXAS) Description
An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website: http://www.exactsciences.com/
